戻る
Omeros Corp (OMER)価格
OMER 株価推移チャート
OMER 収入
Omeros Corp
$12.01
-1.63%
$-0.2
終値： Jan 16, 16:00:00 GMT-5
$12.04
0.3%
$0.03
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$12.21
始値
$12.2
当日レンジ
$11.71 - $12.21
52週レンジ
$2.95 - $17.65
取引高
2.6M
平均取引高
3.6M
1株当たり利益(TTM)
-2.18
配当利回り
--
時価総額
$854.0M
OMERとは何ですか？
Omeros Corp. operates as a biopharmaceutical company. The company is headquartered in Seattle, Washington and currently employs 202 full-time employees. The company went IPO on 2009-10-08. The firm is focused on discovering, developing, and commercializing first-in-class small-molecule and protein therapeutics for both large-market and orphan diseases, with a particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The firm's lead MASP-2 inhibitor, narsoplimab, targets the lectin pathway of complement and is the subject of a biologics license application pending before the FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Its long-acting MASP-2 inhibitor, OMS1029, is in phase I single- and multiple-ascending-dose clinical studies. Its lead phosphodiesterase 7 (PDE7) inhibitor, OMS527, is in clinical development for the treatment of cocaine use disorders. The firm also has preclinical programs, including an oncology platform for the development of novel therapeutics.